ArticleBMC cardiovascular disorders2025
Association of sdLDL-C/LDL-C ratio with atherosclerotic cardiovascular disease: a case-control study.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The small dense LDL cholesterol-glucose index combined with visceral adiposity (sdLG-cVAI) as a novel predictor of incident cardiovascular disease: a prospective cohort study.Lipids in health and disease · 2026Article
- SdLDL‑C/LDL‑C discordance as a practical surrogate for triglyceride‑associated cardiovascular risk: identification of at‑risk lipid phenotypes in the CHARLS prospective cohort.Lipids in health and disease · 2026Article
- Exposure to a PFAS mixture alters cholesterol lipoprotein subfractions and induces a foam cell-like aortic macrophage expression profile in hyperlipidemic LDLrToxicology and applied pharmacology · 2026Article
- Combined discriminative value of SII and sdLDL-C for 1-year major adverse cardiovascular events in patients with unstable angina pectoris.Frontiers in cardiovascular medicine · 2026Article
- Atherogenic Dyslipidemia and Its Association withInternational journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundLow-density lipoprotein cholesterol (LDL-C) and small dense low-density lipoprotein cholesterol (sdLDL-C) are key drivers of atherosclerotic cardiovascular disease (ASCVD) risk. This study aims to investigate the correlation between sdLDL-C/LDL-C ratio and ASCVD to provide new ideas for accurate prediction of ASCVD and identifying high-risk groups.
methodsThe data were derived from patients who visited the Affiliated Hospital of Inner Mongolia Medical University from January 2019 to July 2023. The relationship between the sdLDL-C/LDL-C ratio and the odds of ASCVD was analyzed using univariate and multivariate logistic regression analysis. Subgroup analysis investigates the potential effects of age, sex, hypertension disease heterogeneity, and the relationship between ASCVD.
resultsThe study included 8924 subjects with an average age of (59 ± 11) years. Multivariate logistic regression analysis revealed that compared to the lowest quartile of sdLDL-C/LDL-C ratio, the odds of ASCVD increased by 1.39, 3.48, and 9.34 times in quartile groups 2, 3, and 4, respectively (OR values: 2.39 [95% CI 1.91-2.99], 4.48[95% CI 3.59-5.60], 10.34 [95% CI 8.08-13.22]; P < 0.001). This increasing trend was also observed in stratified analyses by age, hypertension and sex.
conclusionsAn elevated sdLDL-C/LDL-C ratio is associated with an increased odds of ASCVD. The ratio's predictive ability for ASCVD occurrence surpasses that of sdLDL-C alone.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.